
Nafi (Shenzhen) Pharmaceutical Technology
Innovative nasal sprays for rapid treatment of depression and anxiety disorders.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | CNY20.0m | Series A | |
Total Funding | 000k |
Nasal-Phyto specializes in developing innovative nasal spray formulations aimed at providing rapid and effective treatment for depression and anxiety disorders. Operating in the pharmaceutical industry, the company targets healthcare providers and patients seeking fast-acting solutions for mental health conditions. Nasal-Phyto's business model revolves around research and development, clinical trials, and partnerships with larger pharmaceutical companies to bring their products to market. Revenue is generated through product sales, licensing agreements, and strategic collaborations. The company leverages advanced technologies such as nano gold particles and in situ gelling hydrogels to enhance drug delivery across the blood-brain barrier, ensuring quick onset of action and improved patient outcomes.
Keywords: nasal sprays, depression treatment, anxiety disorders, rapid onset, pharmaceutical innovation, mental health, nano gold particles, drug delivery, clinical trials, strategic partnerships.